Let's be extremely conservative here and say 2016 revs come in at 3m... Then the low end of PPS would approx 12-14 cents even if not approved. If Fluticare is approved, it will likely bring revenues between 50-55m after one full year. If market is 6-8 months forward looking, then 1.10 is your number heading towards 2.20 6 months after approval. Then P/E ratio will be more clear and a buyout would reflect a higher multiple. Could go 7 ish if sales are better than expected. Excited about what BH revs bring in near term as well
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.